Skip to content

SEI Investments SEIC Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

State Street logo
State StreetSTT
750M0.0%
Blackrock logo
BlackrockBLK
T Rowe Price Group logo
T Rowe Price GroupTROW
Invesco logo
InvescoIVZ
Ameriprise Financial logo
Ameriprise FinancialAMP
Stifel Financial logo
Stifel FinancialSF

Other financials

Income statement

See full
Revenue$622.2M+12.8%
Operating income$189.5M+20.6%
Net income$174.5M+15.2%
EPS (diluted)$1.40+19.7%

Balance sheet

See full
Cash & equivalents$363.1M-48.9%
Total debt$69.5M+145%
Total equity$2.5B+8.5%
Total assets$396.9M-84.5%

Cash flow

See full
Operating cash flow$221.6M+51.3%
CapEx$6.4M-26.0%
Free cash flow$215.2M+56.1%

Valuation

See full
Market cap$10.76B-2.7%
Enterprise value$10.46B+1.4%
P/E14.6×-3.8×
P/S4.5×-0.6×

Profitability

See full
Operating margin27.9%+0.9pp
Net margin31.2%+3.4pp
FCF margin28%-1.1pp

Returns & leverage

See full
Return on equity31.4%+4.7pp
Debt / equity0.0×
Current ratio4.5×-1.1×

Where this comes from

Reported directly by SEI Investments in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: SEI Investments’s 10-Q, filed April 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about SEI Investments's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SEI Investments's common stock, shares authorized (in shares)?
SEI Investments (SEIC) reported common stock, shares authorized (in shares) of $750M in Q1 2026.
How has SEI Investments's common stock, shares authorized (in shares) changed year-over-year?
SEI Investments's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $750M to $750M.
What is the long-term trend for SEI Investments's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), SEI Investments's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $750M to $750M.